世界の乾癬性関節炎治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04408)
◆英語タイトル:Global Psoriatic Arthritis Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04408
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは乾癬性関節炎治療の世界市場について調査・分析した資料です。種類別(キット、試薬、器具)の市場規模、用途別(病院、診療所、外来手術センター、診断研究所)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別乾癬性関節炎治療の競争状況、市場シェア
・世界の乾癬性関節炎治療市場:種類別市場規模 2015年-2020年(キット、試薬、器具)
・世界の乾癬性関節炎治療市場:種類別市場規模予測 2021年-2026年(キット、試薬、器具)
・世界の乾癬性関節炎治療市場:用途別市場規模 2015年-2020年(病院、診療所、外来手術センター、診断研究所)
・世界の乾癬性関節炎治療市場:用途別市場規模予測 2021年-2026年(病院、診療所、外来手術センター、診断研究所)
・北米の乾癬性関節炎治療市場分析:米国、カナダ
・ヨーロッパの乾癬性関節炎治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの乾癬性関節炎治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の乾癬性関節炎治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの乾癬性関節炎治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Eli Lilly、Roche、Merck、Novartis、Abbvie、Amgen、Bristol Myers Squibb、Celgene Corporation、Janssen、Bausch Health
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Psoriatic Arthritis Treatment Market
The global Psoriatic Arthritis Treatment market size is projected to reach US$ 8155.4 million by 2026, from US$ 7679.9 million in 2020, at a CAGR of 5.7%% during 2021-2026.

Global Psoriatic Arthritis Treatment Scope and Market Size
Psoriatic Arthritis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriatic Arthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Eli Lilly
Roche
Merck
Novartis
Abbvie
Amgen
Bristol Myers Squibb
Celgene Corporation
Janssen
Bausch Health

Market segment by Type, the product can be split into
Kits
Reagents
Instruments
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgery Centers
Diagnostic Laboratories

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psoriatic Arthritis Treatment Revenue
1.4 Market by Type
1.4.1 Global Psoriatic Arthritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kits
1.4.3 Reagents
1.4.4 Instruments
1.5 Market by Application
1.5.1 Global Psoriatic Arthritis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgery Centers
1.5.5 Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Psoriatic Arthritis Treatment Market Perspective (2015-2026)
2.2 Global Psoriatic Arthritis Treatment Growth Trends by Regions
2.2.1 Psoriatic Arthritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Psoriatic Arthritis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Psoriatic Arthritis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Psoriatic Arthritis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Psoriatic Arthritis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Treatment Players by Market Size
3.1.1 Global Top Psoriatic Arthritis Treatment Players by Revenue (2015-2020)
3.1.2 Global Psoriatic Arthritis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Psoriatic Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psoriatic Arthritis Treatment Market Concentration Ratio
3.2.1 Global Psoriatic Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Treatment Revenue in 2019
3.3 Psoriatic Arthritis Treatment Key Players Head office and Area Served
3.4 Key Players Psoriatic Arthritis Treatment Product Solution and Service
3.5 Date of Enter into Psoriatic Arthritis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Psoriatic Arthritis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Psoriatic Arthritis Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Psoriatic Arthritis Treatment Market Size by Application (2015-2020)
5.2 Global Psoriatic Arthritis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Psoriatic Arthritis Treatment Market Size (2015-2020)
6.2 Psoriatic Arthritis Treatment Key Players in North America (2019-2020)
6.3 North America Psoriatic Arthritis Treatment Market Size by Type (2015-2020)
6.4 North America Psoriatic Arthritis Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Psoriatic Arthritis Treatment Market Size (2015-2020)
7.2 Psoriatic Arthritis Treatment Key Players in Europe (2019-2020)
7.3 Europe Psoriatic Arthritis Treatment Market Size by Type (2015-2020)
7.4 Europe Psoriatic Arthritis Treatment Market Size by Application (2015-2020)

8 China
8.1 China Psoriatic Arthritis Treatment Market Size (2015-2020)
8.2 Psoriatic Arthritis Treatment Key Players in China (2019-2020)
8.3 China Psoriatic Arthritis Treatment Market Size by Type (2015-2020)
8.4 China Psoriatic Arthritis Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Psoriatic Arthritis Treatment Market Size (2015-2020)
9.2 Psoriatic Arthritis Treatment Key Players in Japan (2019-2020)
9.3 Japan Psoriatic Arthritis Treatment Market Size by Type (2015-2020)
9.4 Japan Psoriatic Arthritis Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Psoriatic Arthritis Treatment Market Size (2015-2020)
10.2 Psoriatic Arthritis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Psoriatic Arthritis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Psoriatic Arthritis Treatment Market Size by Application (2015-2020)

11 India
11.1 India Psoriatic Arthritis Treatment Market Size (2015-2020)
11.2 Psoriatic Arthritis Treatment Key Players in India (2019-2020)
11.3 India Psoriatic Arthritis Treatment Market Size by Type (2015-2020)
11.4 India Psoriatic Arthritis Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Psoriatic Arthritis Treatment Market Size (2015-2020)
12.2 Psoriatic Arthritis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Psoriatic Arthritis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Psoriatic Arthritis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Psoriatic Arthritis Treatment Introduction
13.1.4 Eli Lilly Revenue in Psoriatic Arthritis Treatment Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Psoriatic Arthritis Treatment Introduction
13.2.4 Roche Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Psoriatic Arthritis Treatment Introduction
13.3.4 Merck Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Psoriatic Arthritis Treatment Introduction
13.4.4 Novartis Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Abbvie
13.5.1 Abbvie Company Details
13.5.2 Abbvie Business Overview
13.5.3 Abbvie Psoriatic Arthritis Treatment Introduction
13.5.4 Abbvie Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.5.5 Abbvie Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Psoriatic Arthritis Treatment Introduction
13.6.4 Amgen Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Details
13.7.2 Bristol Myers Squibb Business Overview
13.7.3 Bristol Myers Squibb Psoriatic Arthritis Treatment Introduction
13.7.4 Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.7.5 Bristol Myers Squibb Recent Development
13.8 Celgene Corporation
13.8.1 Celgene Corporation Company Details
13.8.2 Celgene Corporation Business Overview
13.8.3 Celgene Corporation Psoriatic Arthritis Treatment Introduction
13.8.4 Celgene Corporation Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.8.5 Celgene Corporation Recent Development
13.9 Janssen
13.9.1 Janssen Company Details
13.9.2 Janssen Business Overview
13.9.3 Janssen Psoriatic Arthritis Treatment Introduction
13.9.4 Janssen Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.9.5 Janssen Recent Development
13.10 Bausch Health
13.10.1 Bausch Health Company Details
13.10.2 Bausch Health Business Overview
13.10.3 Bausch Health Psoriatic Arthritis Treatment Introduction
13.10.4 Bausch Health Revenue in Psoriatic Arthritis Treatment Business (2015-2020)
13.10.5 Bausch Health Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Eli Lilly、Roche、Merck、Novartis、Abbvie、Amgen、Bristol Myers Squibb、Celgene Corporation、Janssen、Bausch Health

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の乾癬性関節炎治療市場2026:インサイト・予測(Global Psoriatic Arthritis Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。